1. Diagnosed case of COVID-19 based on RT-PCR or typical CT chest findings. <br/ >Mild COVID-19: Individuals who test positive for SARS-CoV-2 using a virologic test (i.e., a nucleic acid amplification test [NAAT] or an antigen test) and who have any of the various upper respiratory tract symptoms (e.g., cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) with or without fever but who do not have shortness of breath or hypoxia. Sp02 on room air more than 93%. <br/ > <br/ >OR <br/ >Moderate COVID-19: Individuals who test positive for SARS-CoV-2 using a virologic test (i.e., a nucleic acid amplification test [NAAT] or an antigen test), who show evidence of lower respiratory disease during clinical assessment or imaging, and who have an oxygen saturation (SpO2) 90 â?? 93% on room air at sea level or respiratory rate of 24-30 per minute. <br/ > <br/ >2. Presentation within 7 days of onset of fever. <br/ > <br/ >3. Age 18 to 75 years <br/ > <br/ >4. Statin naïve patients (should not use statin for regular 15 days in last one year) <br/ > <br/ >5. Previously documented statin intolerance <br/ > <br/ >6. Unable to provide written informed consent form

1. Diagnosed case of COVID-19 based on RT-PCR or typical CT chest findings. <br/ >Mild COVID-19: Individuals who test positive for SARS-CoV-2 using a virologic test (i.e., a nucleic acid amplification test [NAAT] or an antigen test) and who have any of the various upper respiratory tract symptoms (e.g., cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) with or without fever but who do not have shortness of breath or hypoxia. Sp02 on room air more than 93%. <br/ > <br/ >OR <br/ >Moderate COVID-19: Individuals who test positive for SARS-CoV-2 using a virologic test (i.e., a nucleic acid amplification test [NAAT] or an antigen test), who show evidence of lower respiratory disease during clinical assessment or imaging, and who have an oxygen saturation (SpO2) 90 â?? 93% on room air at sea level or respiratory rate of 24-30 per minute. <br/ > <br/ >2. Presentation within 7 days of onset of fever. <br/ > <br/ >3. Age 18 to 75 years <br/ > <br/ >4. Statin naïve patients (should not use statin for regular 15 days in last one year) <br/ > <br/ >5. Previously documented statin intolerance <br/ > <br/ >6. Unable to provide written informed consent form

1. Diagnosed case of COVID-19 based on RT-PCR or typical CT chest findings. <br/ >Mild COVID-19: Individuals who test positive for SARS-CoV-2 using a virologic test (i.e., a nucleic acid amplification test [NAAT] or an antigen test) and who have any of the various upper respiratory tract symptoms (e.g., cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) with or without fever but who do not have shortness of breath or hypoxia. Sp02 on room air more than 93%. <br/ > <br/ >OR <br/ >Moderate COVID-19: Individuals who test positive for SARS-CoV-2 using a virologic test (i.e., a nucleic acid amplification test [NAAT] or an antigen test), who show evidence of lower respiratory disease during clinical assessment or imaging, and who have an oxygen saturation (SpO2) 90 â?? 93% on room air at sea level or respiratory rate of 24-30 per minute. <br/ > <br/ >2. Presentation within 7 days of onset of fever. <br/ > <br/ >3. Age 18 to 75 years <br/ > <br/ >4. Statin naïve patients (should not use statin for regular 15 days in last one year) <br/ > <br/ >5. Previously documented statin intolerance <br/ > <br/ >6. Unable to provide written informed consent form

1. Diagnosed case of COVID-19 based on RT-PCR or typical CT chest findings. <br/ >Mild COVID-19: Individuals who test positive for SARS-CoV-2 using a virologic test (i.e., a nucleic acid amplification test [NAAT] or an antigen test) and who have any of the various upper respiratory tract symptoms (e.g., cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) with or without fever but who do not have shortness of breath or hypoxia. Sp02 on room air more than 93%. <br/ > <br/ >OR <br/ >Moderate COVID-19: Individuals who test positive for SARS-CoV-2 using a virologic test (i.e., a nucleic acid amplification test [NAAT] or an antigen test), who show evidence of lower respiratory disease during clinical assessment or imaging, and who have an oxygen saturation (SpO2) 90 â?? 93% on room air at sea level or respiratory rate of 24-30 per minute. <br/ > <br/ >2. Presentation within 7 days of onset of fever. <br/ > <br/ >3. Age 18 to 75 years <br/ > <br/ >4. Statin naïve patients (should not use statin for regular 15 days in last one year) <br/ > <br/ >5. Previously documented statin intolerance <br/ > <br/ >6. Unable to provide written informed consent form